Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-053933
Filing Date
2026-08-06
Accepted
2026-08-06 08:46:37
Documents
72
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brns-20260630.htm   iXBRL 10-Q 1053452
2 EX-31.1 brns-20260630xexx311.htm EX-31.1 11165
3 EX-32.1 brns-20260630xexx321.htm EX-32.1 5741
  Complete submission text file 0001628280-26-053933.txt   5751087

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brns-20260630.xsd EX-101.SCH 48736
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT brns-20260630_cal.xml EX-101.CAL 65908
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brns-20260630_def.xml EX-101.DEF 151811
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brns-20260630_lab.xml EX-101.LAB 564958
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brns-20260630_pre.xml EX-101.PRE 359261
76 EXTRACTED XBRL INSTANCE DOCUMENT brns-20260630_htm.xml XML 651951
Mailing Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874
Business Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40367 | Film No.: 261246401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)